Manufactured on GF’s 22FDX platform, Movano’s radio frequency-enabled solution will help individuals to manage their glucose levels anywhere, anytime
GlobalFoundries Global Technology Conference
Pleasanton and Santa Clara, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) — Movano Inc., a health-focused technology company developing non-invasive solutions to enhance the quality of life for people affected by chronic health conditions, today announced a strategic collaboration with GLOBALFOUNDRIES® (GF®) to advance the commercialization of Movano’s wearable, non-invasive continuous glucose monitor (CGM), which is currently in development. The announcement was made at GF’s annual Global Technology Conference (GTC).
Movano’s novel approach to glucose monitoring is based on its patent-pending radio frequency (RF) sensor platform, which is built on GF’s 22FDX® (22nm FD-SOI) solution, to enable the creation of high performance and small form-factor sensors that are low-power and cost-effectively manufactured at scale.
“The last few months have spurred a growing need for